Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,090 public trials 2,046 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Whole-body MRI in Pediatric Hodgkin's Lymphoma

NCT04005703

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
Locations: LKH-Universitätsklinikum Graz Graz, Austria

Ospedale Giannina Gaslini Genova, Italy

Academic Medical Center Amsterdam Amsterdam, Netherlands

VU University Medical Center Amsterdam, Netherlands

View Trial Details

Completed

Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia

NCT01914484

Conditions: Accelerated Phase Chronic Myeloid Leukemia, Blast Crisis, Blastic Phase Chronic Myeloid Leukemia, +27 more
Locations: Princess Margaret Hospital / University Health Network Toronto, Ontario, Canada

View Trial Details

Completed

Indications and Outcomes in Kidney-ureteral Pediatric Lithiasis: Experience of Parma

NCT04605315

Conditions: Calculi, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +20 more
Locations: AOU Parma Parma, Italy

View Trial Details

Completed

An Observational Study of Patients With Malignant Lymphomas Treated With MabThera® SC in Everyday Clinical Practice

NCT02240316

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Universitätsklinikum Essen; Klinik für Hämatologie Essen, Germany

View Trial Details

Completed

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

NCT03538028

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +105 more
Locations: The Angeles Clinic and Research Center Los Angeles, California, United States

Hackensack Medical Center Hackensack, New Jersey, United States

Carolina BioOncology Institute Huntersville, North Carolina, United States

Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Completed

Cohort Study for Severe Ischaemic Stroke

NCT03222024

Conditions: Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +21 more
Locations: West China Hospital, Sichuan University Chengdu, Sichuan, China

View Trial Details

Completed

Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II Study

NCT02113800

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +20 more
Locations: Charité-Universitätsmedizin, Medizinische Klinik m. S. Hepatologie und Gastroenterologie, Campus Virchow-Klinikum Berlin, Germany

View Trial Details

Completed

Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation

NCT00859586

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +22 more
Locations: National Institutes of Health Bethesda, Maryland, United States

View Trial Details

Completed

Tocilizumab for KSHV-Associated Multicentric Castleman Disease

NCT01441063

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Castleman Disease, +29 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia (WM)

NCT00422799

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions